Metabolic syndrome, characterized by a group of cardiovascular risk factors, including insulin resistance, high blood pressure, high blood glucose levels, low HDL cholesterol levels, high triglyceride levels, and abdominal obesity, is associated with increased cholesterol secretion and gallstone formation (Shabanzadeh, Skaaby, Sorensen, Eugen-Olsen 2017
ATP serves as a shuttle, delivering energy to places within the cell where energy-consuming chemical activities are taking place
Typically, GLP-1 receptor agonists are recommended for individuals with a BMI of 30 kg/m or higher, classified as obesity, or for those with a BMI of at least 27 kg/m who also have obesity-related health conditions such as hypertension, type 2 diabetes , or high cholesterol
However, there is no evidence that the medication's efficacy for weight loss or glycemic control is diminished in patients without gallbladders
Semaglutide is one of the most widely prescribed GLP-1 medications for chronic weight management
Obesity is a complex, chronic condition influenced by biology, environment, and behavior
